Physician

Emmanuel E. Zervos, MD

According to 2025 Medicare claims, Emmanuel Zervos, MD (NPI: 1154333284) practices surgical oncology in the Greenville, NC market, with the plurality of this provider's patient population coming from Pitt, NC. This provider's primary affiliated billing organization is VIDANT MEDICAL GROUP LLC (NPI: 1477648731; TIN: 383740839) and primary practice location at 27834-2818. Zervos is affiliated with the Coastal Plains Network, LLC (ACO ID: A2684), participating under the MSSP model.

Zervos' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 135 traditional Medicare patients, billed 309 HCPCS/CPT codes, and received $57,461 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 119 prescription claims across 53 beneficiaries totaling $38,258 in drug costs, led by Creon (Lipase/Protease/Amylase). DME data shows 66 claims. Open Payments data shows 1 records totaling $148. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $137,746 to $57,461. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $32,820 and ending at $38,258. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $4,953 to $2,789.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	236	863	$137,746
2016	252	743	$161,716
2017	325	928	$158,786
2018	214	427	$97,085
2019	140	274	$55,478
2020	184	393	$58,993
2021	142	359	$58,033
2022	151	304	$55,347
2023	167	336	$71,457
2024	135	309	$57,461

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	52	190	$32,820
2016	56	128	$27,191
2017	58	148	$28,112
2018	36	104	$61,578
2019	28	94	$90,301
2020	34	88	$44,911
2021	26	73	$45,385
2022	36	93	$49,034
2023	41	121	$66,427
2024	53	119	$38,258

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	98	$5,115
2016	N/R	97	$3,331
2017	N/R	86	$28,834
2018	N/R	87	$3,372
2019	N/R	178	$60,900
2020	N/R	68	$3,212
2021	N/R	44	$2,133
2022	N/R	48	$2,319
2023	N/R	100	$47,501
2024	N/R	66	$4,994

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	34	34	$92
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	44	68	$75
99442	Telephone medical discussion with physician, 11-20 minutes	13	14	$62
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	59	73	$48

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Creon	Lipase/Protease/Amylase	22	614	$36,159
Neomycin Sulfate	Neomycin Sulfate	29	36	$148
Metronidazole	Metronidazole	30	33	$41

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4407	Ostomy skin barrier, with flange (solid, flexible, or accordion), extended wear, with built-in convexity, 4 x 4 inches or smaller, each	N	N/R	11	$2,061
A4409	Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, 4 x 4 inches or smaller, each	N	N/R	11	$1,461
A5063	Ostomy pouch, drainable; for use on barrier with flange (2 piece system), each	N	N/R	22	$1,273
A4452	Tape, waterproof, per 18 square inches	N	N/R	11	$169
A4394	Ostomy deodorant, with or without lubricant, for use in ostomy pouch, per fluid ounce	N	N/R	11	$30

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$148	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Emmanuel E. Zervos, MD?

Tedicare shows public-source Medicare data for Emmanuel E. Zervos, MD (NPI 1154333284), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Emmanuel E. Zervos, MD have ACO affiliation data?

Emmanuel E. Zervos, MD is shown with ACO affiliation data for Coastal Plains Network, LLC (MSSP, ACO ID A2684).

What billing organization is linked to Emmanuel E. Zervos, MD?

Emmanuel E. Zervos, MD is linked to VIDANT MEDICAL GROUP LLC (billing NPI 1477648731) in the available physician profile data.

Does Emmanuel E. Zervos, MD have Open Payments data?

Emmanuel E. Zervos, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.